Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart
failure cases and has a prevalence that is expected to rise with the growing ageing …

Heart failure (HF) is a heterogeneous clinical syndrome marked by substantial morbidity and
mortality. The natural history of HF is well established; however, epidemiological data are …

Aims The aim of this analysis was to provide data on the overall comorbidity burden, both
cardiovascular (CV) and non‐CV, in a large real‐world heart failure (HF) population across …

Obesity is a major public health challenge worldwide. It is costly, predisposes to many
cardiovascular (CV) diseases (CVD), is increasing at an alarming rate, and …

The global prevalence of obesity has more than doubled over the past four decades,
currently affecting more than a billion individuals. Beyond its recognition as a high-risk …

Background Obesity is associated with adverse cardiac remodeling and is a key driver for
the development and progression of heart failure (HF). Once-weekly semaglutide (2.4 ámg) …

To tackle the burden of obesity-induced cardiometabolic disease, the scientific community
relies on accurate and reproducible adiposity measurements in the clinic. These …

Obesity, and the associated metabolic syndrome, is a risk factor for increased disease
severity with a variety of infectious agents, including influenza virus. Yet, the mechanisms …

The obesity survival paradox has been observed in patients with chronic heart failure (HF)
for longer than 20 years. 1 Body mass index (BMI), defined as the body weight (kg) divided …

Heart failure (HF) is a major health issue, affecting up to 2% of the adult population
worldwide. Given the increasing prevalence of obesity and its association with various …